全文获取类型
收费全文 | 3431826篇 |
免费 | 250794篇 |
国内免费 | 9211篇 |
专业分类
耳鼻咽喉 | 46434篇 |
儿科学 | 113181篇 |
妇产科学 | 95726篇 |
基础医学 | 481726篇 |
口腔科学 | 94768篇 |
临床医学 | 314620篇 |
内科学 | 673662篇 |
皮肤病学 | 81386篇 |
神经病学 | 282368篇 |
特种医学 | 130783篇 |
外国民族医学 | 1111篇 |
外科学 | 512358篇 |
综合类 | 74063篇 |
现状与发展 | 7篇 |
一般理论 | 1334篇 |
预防医学 | 267505篇 |
眼科学 | 77699篇 |
药学 | 248286篇 |
8篇 | |
中国医学 | 7250篇 |
肿瘤学 | 187556篇 |
出版年
2019年 | 27433篇 |
2018年 | 38481篇 |
2017年 | 29545篇 |
2016年 | 33950篇 |
2015年 | 38237篇 |
2014年 | 53277篇 |
2013年 | 79979篇 |
2012年 | 106724篇 |
2011年 | 113208篇 |
2010年 | 67827篇 |
2009年 | 64746篇 |
2008年 | 105222篇 |
2007年 | 111639篇 |
2006年 | 113485篇 |
2005年 | 109203篇 |
2004年 | 104731篇 |
2003年 | 100989篇 |
2002年 | 97577篇 |
2001年 | 165396篇 |
2000年 | 169450篇 |
1999年 | 142487篇 |
1998年 | 41206篇 |
1997年 | 36692篇 |
1996年 | 36718篇 |
1995年 | 35506篇 |
1994年 | 32420篇 |
1993年 | 30337篇 |
1992年 | 110009篇 |
1991年 | 105601篇 |
1990年 | 102326篇 |
1989年 | 98570篇 |
1988年 | 90422篇 |
1987年 | 88583篇 |
1986年 | 82975篇 |
1985年 | 79406篇 |
1984年 | 59539篇 |
1983年 | 50467篇 |
1982年 | 30173篇 |
1981年 | 26900篇 |
1979年 | 52626篇 |
1978年 | 37246篇 |
1977年 | 31390篇 |
1976年 | 29244篇 |
1975年 | 30831篇 |
1974年 | 36712篇 |
1973年 | 35097篇 |
1972年 | 32984篇 |
1971年 | 30505篇 |
1970年 | 28347篇 |
1969年 | 26992篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignancies
Bayard L. Powell Hyman B. Muss Robert L. Capizzi Mary E. Caponera Douglas R. White Patricia J. Zekan James N. Atkins Don V. Jackson Jr. Frederick Richards II John B. Craig Julia M. Cruz Charles L. Spurr 《Cancer chemotherapy and pharmacology》1987,19(3):250-252
Summary Cytosine arabinsodie (ara-C) and etoposide (VP-16) display synergy in the laboratory. Twenty-six patients participated in a phase I study of high-dose ara-C in combination with VP-16. The dose of VP-16 was held constant at 50 mg/m2 as an intermittent infusion over 33 h; escalating doses of ara-C were given as infusions during hours 9–12 and 21–24. Myelosuppression was the dose-limiting toxicity and occurred with doses considerably less than those expected from studies of the two drugs as single agents. The suggested initial doses for phase II trials with this schedule are 750 mg/m2×2 doses of ara-C and 50 mg/m2 of VP-16. Nonhematologic toxicity was minimal; therefore, further dose escalation is feasible in patients in whom myelosuppression is acceptable.Supported in part by grants from the National Cancer Institute (CA-12197 and CA-09422) and the American Cancer Society CF-85-182 相似文献
992.
H Nakagawa M Kikuhara M Sato K Sakai S Kimura 《Gan to kagaku ryoho. Cancer & chemotherapy》1987,14(9):2767-2770
A 50-year-old woman with bilateral inflammatory breast cancer (T4, N1b, M1, Stage IV) underwent right extended radical mastectomy and left modified radical mastectomy following pre-operative administration of carcinostatics (ADM, 5-FU) and irradiation. However, tumor recurrence was observed at the skin and right pleural cavity after the operation. Adriamycin-containing combination chemotherapy and radiation therapy were performed, but no significant response was obtained. CDDP was then administered intravenously at a daily dose of 62.5 mg/m2 at intervals of 60 days. The pleural effusion disappeared and the extent of skin metastasis was reduced, resulting in partial response which lasted for 90 days. The serum CEA level decreased from 13.1 ng/ml to 2.3 ng/ml. As the side effects of this therapy, slight nausea, vomiting and general fatigue were observed. This result suggested that CDDP is an effective drug for inflammatory breast cancer. 相似文献
993.
Platelet antibodies in systemic lupus erythematosus 总被引:2,自引:0,他引:2
C. Kaplan P. Champeix D. Blanchard J. Y. Muller J. P. Cartron 《British journal of haematology》1987,67(1):89-93
In systemic lupus erythematosus (SLE), the precise cause of the thrombocytopenia is unknown. Since platelet associated IgG is increased in many patients, it has been suggested that the destruction of platelets might be dependent on specific antibodies. In nine patients with SLE, platelet associated immunoglobulins were found together with free serum antibody which bound to platelets from all normal subjects. Using an immunoblotting technique with membrane proteins from normal platelets incubated with patient sera, target antigens were localized on a band of mol wt 108,000 in two cases (B. and N.) and on a band of mol wt 66,000 in a third (M.). When the same technique was applied to autologous platelets of patient N., autoantibody binding to the protein of mol wt 108,000 was demonstrated. The antigenic determinants were not removed from the platelets by enzyme treatment or by disulphide bond reduction, and were localized in the cytoplasmic fraction of the platelets. 相似文献
994.
995.
996.
We investigated the effects of imaging and display conditions on the detectability of low-contrast objects in digital subtraction angiographic (DSA) images. The test images were produced by superimposition of low-contrast objects on a uniform noisy background obtained with a DSA system. We employed 18-alternative forced-choice (18-AFC) experiments and predictions based on statistical decision theory to study the dependence of the threshold contrasts of the test objects on the object size, incident x-ray exposure, display window width, and display medium. The results indicated that the threshold contrast decreased with increasing object size, and that the detectability of an object of a given size increased with increasing incident x-ray exposure and decreasing width of the display window. We found that the signal-to-noise ratio (SNR) obtained from the perceived statistical decision theory model, which includes the observer's internal noise, can accurately predict the detectability of low-contrast objects in DSA images. The threshold SNR corresponding to 50% correct detection in the 18-AFC experiments had a constant value of 3.8, in agreement with results reported previously for screen-film systems. The theoretical model will be useful for prediction of the performance of a DSA system based on its physical characteristics, and for evaluation of the tradeoff between patient exposure and diagnostic accuracy for a given DSA unit. 相似文献
997.
998.
999.
1000.
The family physician should follow the small premature infant in the neonatal intensive care center and review the baby's problems and risk factors. In the office, special attention is required in monitoring the infant. Proper hospital and office care greatly improve the prognosis. 相似文献